Evidence map›Paper›PMID 28699486›Full record

ReviewCurrent neuropharmacology2018

Stress, Depression, Resilience and Ageing: A Role for the LPA-LPA1 Pathway.

Roman Dario Moreno-Fernandez, Sara Tabbai, Estela Castilla-Ortega, Margarita Perez-Martin, Guillermo Estivill-Torrus, Fernando Rodriguez de Fonseca, Luis Javier Santin, Carmen Pedraza

Open access · greenAbstract readReview
In one paragraph

Review in Current neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Lipids as Regulators of Cellular Senescence.Frontiers in physiology · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Effects of the LPAFrontiers in molecular neuroscience · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Roman Dario Moreno-FernandezDepartamento de Psicobiologia y Metodología de las CC, Instituto de Investigacion Biomedica de Malaga (IBIMA), Universidad de Malaga; Malaga 29071, Spain.
Sara TabbaiDepartamento de Psicobiologia y Metodología de las CC, Instituto de Investigacion Biomedica de Malaga (IBIMA), Universidad de Malaga; Malaga 29071, Spain.
Estela Castilla-OrtegaUnidad de Gestion Clínica de Salud Mental, Instituto de Investigacion Biomedica de Malaga (IBIMA), Hospital Regional Universitario de Malaga; Malaga 29010, Spain.
Margarita Perez-MartinDepartamento de Biologia Celular, Genetica y Fisiologia, Instituto de Investigacion Biomedica de Malaga (IBIMA), Universidad de Malaga; Malaga 29071, Spain.
Guillermo Estivill-TorrusUnidad de Gestion Clinica de Neurociencias, Instituto de Investigacion Biomedica de Malaga (IBIMA), Hospital Regional Universitarios de Malaga, Malaga, Spain.
Fernando Rodriguez de FonsecaUnidad de Gestion Clínica de Salud Mental, Instituto de Investigacion Biomedica de Malaga (IBIMA), Hospital Regional Universitario de Malaga; Malaga 29010, Spain.
Luis Javier SantinDepartamento de Psicobiologia y Metodología de las CC, Instituto de Investigacion Biomedica de Malaga (IBIMA), Universidad de Malaga; Malaga 29071, Spain.
Carmen PedrazaDepartamento de Psicobiologia y Metodología de las CC, Instituto de Investigacion Biomedica de Malaga (IBIMA), Universidad de Malaga; Malaga 29071, Spain.
Universidad de Málaga · ESInstituto de Investigación Biomédica de Málaga · ESHospital Regional Universitario de Málaga · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic stress affects health and the quality of life, with its effects being particularly relevant in ageing due to the psychobiological characteristics of this population. However, while some people develop psychiatric disorders, especially depression, others seem very capable of dealing with adversity. There is no doubt that along with the identification of neurobiological mechanisms involved in developing depression, discovering which factors are involved in positive adaptation under circumstances of extreme difficulty will be crucial for promoting resilience.

methodsHere, we review recent work in our laboratory, using an animal model lacking the LPA1 receptor, together with pharmacological studies and clinical evidence for the possible participation of the LPA1 receptor in mood and resilience to stress.

resultsSubstantial evidence has shown that the LPA1 receptor is involved in emotional regulation and in coping responses to chronic stress, which, if dysfunctional, may induce vulnerability to stress and predisposition to the development of depression. Given that there is commonality of mechanisms between those involved in negative consequences of stress and in ageing, this is not surprising, considering that the LPA1 receptor may be involved in coping with adversity during ageing.

conclusionAlterations in this receptor may be a susceptibility factor for the presence of depression and cognitive deficits in the elderly population. However, because this is only a promising hypothesis based on previous data, future studies should focus on the involvement of the LPA-LPA1 pathway in coping with stress and resilience in ageing.

Indexed as

Resilience, PsychologicalAgingAnimalsBrainDepressionHumansLysophospholipidsReceptors, Lysophosphatidic AcidStress, PsychologicalLysophospholipidsReceptors, Lysophosphatidic Acidageinglimbic systemLPA1 receptorLPA-LPA1 pathway receptorresiliencestress

Identifiers

PMID28699486
PMCPMC5843979
OpenAlexW2743082674

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.